Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Katsuyoshi Hashine"'
Publikováno v:
IJU Case Reports, Vol 7, Iss 4, Pp 341-345 (2024)
Introduction The pathologic evaluation and clinical course of cytoreductive nephrectomy after combined immuno‐oncology therapy were reviewed to understand the benefits of cytoreductive nephrectomy. Case presentation Three patients with clear cell c
Externí odkaz:
https://doaj.org/article/55ab77128c0c4c38afaf6526e0836f71
Autor:
Takumasa Takemoto, Ikuko Kiriyama, Yoshifumi Sugawara, Chie Abe, Norihiro Teramoto, Katsuyoshi Hashine, Isao Yoshida, Akinori Asagi
Publikováno v:
Radiology Case Reports, Vol 19, Iss 6, Pp 2224-2229 (2024)
Adrenal leiomyomas are rare and often reported as Epstein-Barr virus (EBV)-associated smooth muscle tumor (SMT) in association with EBV infection in immunocompromised patients. We experienced a case of right adrenal leiomyoma that was incidentally fo
Externí odkaz:
https://doaj.org/article/91ac245ed1f049de8fc0d20632890b50
Publikováno v:
Urology Annals, Vol 15, Iss 1, Pp 60-67 (2023)
Purpose: The study was performed to examine patient-reported outcomes (PROs) in the 1st year after surgery and the institutional learning curve after the introduction of robot-assisted radical prostatectomy (RARP). Materials and Methods: The subjects
Externí odkaz:
https://doaj.org/article/d3f6eefd69a84f98bafa8b52c19a39f9
Autor:
Kenichi Nishimura, Noriyoshi Miura, Naoya Sugihara, Keisuke Funaki, Kanae Koyama, Yuichiro Sawada, Terutaka Noda, Tetsuya Fukumoto, Yuki Miyauchi, Tadahiko Kikugawa, Takashi Saika, Masafumi Matsumura, Katsuyoshi Hashine, Mashio Taniwaki
Publikováno v:
BMC Urology, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Currently, immunotherapy is indicated for patients with metastatic RCC or unresectable RCC, but there is no indication for immunotherapy in the neoadjuvant setting. We report a case in which the combined use of nivolumab and ipili
Externí odkaz:
https://doaj.org/article/dcf71a3e400f4659a622a3fda712748e
Autor:
Akira Yokomizo, Hirofumi Koga, Kazuto Ito, Yutaka Takezawa, Motokiyo Komiyama, Kazuo Nishimura, Junji Yonese, Katsuyoshi Hashine, Naoya Masumori, Gaku Arai, Shiro Saito, Mitsuru Shinohara, Nobuaki Shimizu, Atsushi Yamauchi, Takefumi Satoh, Tatsuo Tochigi, Mikio Kobayashi, Hiroyuki Fujimoto, Ken‐ichi Kakimoto, Iwao Fukui, Taiji Tsukamoto, Miwako Nozaki, Katsuyuki Karasawa, Masaru Hasumi, Mikinobu Ohtani, Hiromichi Ishiyama, Masaaki Kuwahara, Masaoki Harada, Yasuo Ohashi, Toshihiko Kotake, Tadao Kakizoe, Kazuhiro Suzuki, Seiji Naito, Hidetoshi Yamanaka, National Research Project on Endocrine‐Radiation Combination Therapy for Locally Advanced Prostate Cancer investigators
Publikováno v:
Cancer Medicine, Vol 10, Iss 10, Pp 3240-3248 (2021)
Abstract Background We evaluated patient‐reported outcomes (PRO) during neoadjuvant androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) followed by either adjuvant continuous ADT (CADT) or intermittent ADT (IADT) for pati
Externí odkaz:
https://doaj.org/article/4fc6d5a819fc4ff3b13b667c17fde309
Publikováno v:
Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-8 (2018)
Abstract Background There have been few reports on health-related quality of life (HRQOL) after laparoscopic radical prostatectomy (LRP) in Japanese patients. The aim of this study is to assess changes in HRQOL during 36 months after LRP compared wit
Externí odkaz:
https://doaj.org/article/de0a810f2f254baaa5a3bcfdf76c3668
Autor:
Katsuyoshi Hashine, Takehiro Ide, Takeshi Nakashima, Tadanori Hosokawa, Iku Ninomiya, Norihiro Teramoto
Publikováno v:
Urology Annals, Vol 8, Iss 1, Pp 10-15 (2016)
Background: The aim of this study was to examine the histological outcome and potential therapeutic benefit of second transurethral resection (TUR) for high-grade T1 bladder cancer. Patients and Methods: The subjects were 171 patients who underwent i
Externí odkaz:
https://doaj.org/article/f6c9afece88f486199808027277ac4d7
Autor:
Siew-Kee Low, Koya Fukunaga, Atsushi Takahashi, Koichi Matsuda, Fumiya Hongo, Hiroyuki Nakanishi, Hiroshi Kitamura, Takamitsu Inoue, Yoichiro Kato, Yoshihiko Tomita, Satoshi Fukasawa, Tomoaki Tanaka, Kazuo Nishimura, Hirotsugu Uemura, Isao Hara, Masato Fujisawa, Hideyasu Matsuyama, Katsuyoshi Hashine, Katsunori Tatsugami, Hideki Enokida, Michiaki Kubo, Tsuneharu Miki, Taisei Mushiroda
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148177 (2016)
Sunitinib is a tyrosine kinase inhibitor and used as the first-line treatment for advanced renal cell carcinoma (RCC). Nevertheless, inter-individual variability of drug's toxicity was often observed among patients who received sunitinib treatment. T
Externí odkaz:
https://doaj.org/article/a276813a941f4f4aa59c01e5e9edcb45
Autor:
Nishimoto, Koshiro, Kenichi, Nakajima, Masafumi, Oyama, Go, Kaneko, Satoru, Takahashi, Hideyasu, Matsuyama, Hiroaki, Shiina, Tomohiko, Ichikawa, Hiroyuki, Horikoshi, Katsuyoshi, Hashine, Yutaka, Sugiyama, Takeshi, Miyao, Manabu, Kamiyama, Kenichi, Harada, Akito, Ito, Atsushi, Mizokami
Publikováno v:
International Journal of Urology. 29:1477-1487
Novel androgen receptor axis-targeted agents (ARATAs) have been developed for mCRPC and improved overall survival (OS). Here, we aimed to find predictors who will receive the greatest benefits from ARATAs.We previously performed a multicenter study t
Autor:
Taiki, Kamijima, Hiroshi, Yaegashi, Atsushi, Mizokami, Kenichi, Nakajima, Hideyasu, Matsuyama, Tomohiko, Ichikawa, Koshiro, Nishimoto, Satoru, Takahashi, Hiroaki, Shiina, Hiroyuki, Horikoshi, Katsuyoshi, Hashine, Yutaka, Sugiyama, Takeshi, Miyao, Manabu, Kamiyama, Kenichi, Harada, Akito, Ito, Hideki, Enokida
Publikováno v:
Anticancer Research. 42:3099-3108
This study aimed to evaluate the therapeutic benefit of novel androgen receptor-targeted agents (ARTAs) in castration-resistant prostate cancer (CRPC) with bone metastases in Japan.In followup to our prospective observational study (PROSTAT-BSI) from